IP Library Granted Patent US 8,242,310
Granted Patent B2
US 8,242,310 · App. 12/556,479 · Granted Aug 14, 2012

Processes for the preparation of aminosulfone compounds

Assignee: Celgene Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,242,310
App. No.
12/556,479
Granted
Aug 14, 2012
Kind
B2
Abstract

Processes for synthesizing aminosulfone compounds are provided. Aminosulfone compounds obtained using methods provided herein are useful in production or synthesis of isoindoline based PDE 4 modulators.

Claims (29)

1. A process for preparing a compound of Formula (I):

or a salt, or stereoisomer thereof, wherein R 1 and R 2 are each independently hydrogen, substituted or unsubstituted (C 1 -C 6 )alkyl, substituted or unsubstituted (C 1 -C 6 )alkoxy, (C 3 -C 18 )cycloalkyl, cyano, or (C 3 -C 18 )cycloalkyl-(C 1 -C 6 )alkoxy, comprising the steps of:

(1) reacting a nitrile of Formula (III):

with LiCH 2 SO 2 CH 3 , to form an enamine of Formula (IV):

(2) reducing the enamine of Formula (IV) to form the compound of Formula (I) or a salt thereof.

2. The process of claim 1 , wherein the nitrile of Formula (III) is formed by reacting an aldehyde of Formula (II):

with hydroxylamine, or a salt thereof.

3. The process of claim 2 , wherein the reaction between the aldehyde of Formula (II) and hydroxylamine, or a salt thereof, occurs in a solvent, wherein the solvent is ethyl acetate, acetone, methyl ethyl ketone, diethyl ether, tetrahydrofuran, acetonitrile, dichloromethane, chloroform, N-methylpyrrolidinone, dimethyl formamide, dimethyl sulfoxide, formic acid, acetic acid, and a combination thereof.

4. The process of claim 2 , wherein the reaction between the aldehyde of Formula (II) and hydroxylamine, or a salt thereof, occurs at a temperature between about 10° C. and about 90° C.

5. The process of claim 1 , wherein LiCH 2 SO 2 CH 3 is prepared by reacting Me 2 SO 2 with n-BuLi.

6. The process of claim 5 , wherein the reaction between Me 2 SO 2 and n-BuLi occurs in a solvent, wherein the solvent is diethyl ether, tetrahydrofuran, N-methylpyrrolidinone, MTBE, glyme, diglyme, toluene, xylene, hexanes, or a combination thereof.

7. The process of claim 5 , wherein the reaction between Me 2 SO 2 and n-BuLi occurs at a temperature between about 0° C. and about 20° C.

8. The process of claim 1 , wherein the reaction between the nitrile of Formula (III) and LiCH 2 SO 2 CH 3 occurs in a solvent, wherein the solvent is diethyl ether, tetrahydrofuran, N-methylpyrrolidinone, MTBE, glyme, diglyme, toluene, xylene, hexanes, or a combination thereof.

9. The process of claim 1 , wherein the reaction between the nitrile of Formula (III) and LiCH 2 SO 2 CH 3 occurs at a temperature between about 0° C. and about 60° C.

10. The process of claim 1 , wherein the enamine of Formula (IV) is reduced by NaBH(OAc) 3 .

11. The process of claim 1 , wherein the enamine of Formula (IV) is reduced by NaBH 4 .

12. The process of claim 1 , wherein the reduction of the enamine of Formula (IV) occurs in the presence of an acid, wherein the acid is acetic acid, methanesulfonic acid, trifluoroacetic acid, 4-(trifluoromethyl)benzoic acid, p-toluenesulfonic acid, hydrochloric acid, nitric acid, sulfuric acid, phosphoric acid, or a combination thereof.

13. The process of claim 1 , wherein the reduction of the enamine of Formula (IV) occurs in a solvent, wherein the solvent is ethyl acetate, diethyl ether, tetrahydrofuran, acetic acid, acetonitrile, N-methylpyrrolidinone, dimethylformamide, dimethyl sulfoxide, hexanes, or a combination thereof.

14. The process of claim 1 , wherein the reduction of the enamine of Formula (IV) occurs at a temperature between about 0° C. and about 25° C.

15. The process of claim 1 , wherein the reduction of the enamine of Formula (IV) forms a salt of Formula (I).

16. The process of claim 15 , wherein the salt of Formula (I) is hydrolyzed to provide the compound of Formula (I).

17. The process of claim 16 , wherein the hydrolysis occurs at a temperature between about 0° C. and about 80° C.

18. The process of claim 16 , wherein the hydrolysis occurs in the presence of a base, wherein the base is NaOH, KOH, LiOH, Ca(OH) 2 , or a combination thereof.

19. The process of claim 16 , wherein the hydrolysis occurs in the presence of an acid, wherein the acid is trifluoroacetic acid, 4-(trifluoromethyl)benzoic acid, p-toluenesulfonic acid, methanesulfonic acid, acetic anhydride, a Lewis acid, or a combination thereof.

20. The process of claim 1 , wherein R 1 and R 2 are both (C 1 -C 6 )alkoxy.

21. The process of claim 1 , wherein R 1 and R 2 are both (C 1 -C 6 )alkyl.

22. The process of claim 1 , wherein one of R 1 and R 2 is (C 1 -C 6 )alkoxy, and the other of R 1 and R 2 is (C 1 -C 6 )alkyl.

23. The process of claim 1 , wherein R 1 is methoxy, and R 2 is ethoxy.

24. The process of claim 1 , wherein one of R 1 and R 2 is (C 1 -C 6 )alkoxy and the other of R 1 and R 2 is (C 3 -C 6 )cycloalkoxy.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 4, 2019
From: CELGENE CORPORATION
To: AMGEN INC.
Reel/Frame 051181/0038 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 2, 2009
From: SAINDANE, MANOHAR T.; GE, CHUANSHENG
To: CELGENE CORPORATION
Reel/Frame 023596/0295 →
Continuity (2)
Provisional Application 61095902 · Sep 10, 2008
Related Publication 20100168475A1 · Jul 1, 2010